|Place of Origin:||China|
|Model Number:||1.125g, 2.25g, 4.5g|
|Minimum Order Quantity:||100, 000 vials|
|Packaging Details:||50 vials/box|
|Payment Terms:||L/C, T/T|
|Supply Ability:||500, 000 vials per day|
|Product:||Piperacillin Sodium And Tazobactam Sodium For Injection 8:1||Specification:||1.125g, 2.25g, 4.5g|
|Standard:||BP, USP||Packing:||50 Vials/box|
Polymicrobial Dry Powder Injection Piperacillin Tazobactam Sodium for Injection
Product : Piperacillin sodium and Tazobactam sodium For Injection 8:1
Specification : 1.125g, 2.25g, 4.5g
Standard : BP, USP
Packing : 50vials/box
Piperacillin is a semisynthetic, broad-spectrum, ampicillin derived ureidopenicillin antibiotic proposed for pseudomonas infections. It is also used in combination with other antibiotics.
Tazobactam is a antibacterial penicillin derivative which inhibits the action of bacterial beta-lactamases.
For the treatment of polymicrobial infections.
Piperacillin is a penicillin beta-lactam antibiotic used in the treatment of bacterial infections caused by susceptible, usually gram-positive, organisms. The name "penicillin" can either refer to several variants of penicillin available, or to the group of antibiotics derived from the penicillins. Piperacillin has in vitro activity against gram-positive and gram-negative aerobic and anaerobic bacteria. The bactericidal activity of Piperacillin results from the inhibition of cell wall synthesis and is mediated through Piperacillin binding to penicillin binding proteins (PBPs). Piperacillin is stable against hydrolysis by a variety of beta-lactamases, including penicillinases, and cephalosporinases and extended spectrum beta-lactamases.
Mechanism of action
By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, Piperacillin inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that Piperacillin interferes with an autolysin inhibitor.